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Abstract
Thoracic tumours are increasingly considered indications for pencil beam scanned proton therapy
(PBS-PT) treatments. Conservative robustness settings have been suggested due to potential range
straggling effects caused by the lung micro-structure. Using proton radiography (PR) and a 4D
porcine lung phantom, we experimentally assess range errors to be considered in robust treatment
planning for thoracic indications. A human-chest-size 4D phantom hosting inflatable porcine
lungs and corresponding 4D computed tomography (4DCT) were used. Five PR frames were
planned to intersect the phantom at various positions. Integral depth-dose curves (IDDs) per
proton spot were measured using a multi-layer ionisation chamber (MLIC). Each PR frame
consisted of 81 spots with an assigned energy of 210 MeV (full width at half maximum (FWHM)
8.2 mm). Each frame was delivered five times while simultaneously acquiring the breathing signal
of the 4D phantom, using an ANZAI load cell. The synchronised ANZAI and delivery log file
information was used to retrospectively sort spots into their corresponding breathing phase. Based
on this information, IDDs were simulated by the treatment planning system (TPS) Monte Carlo
dose engine on a dose grid of 1 mm. In addition to the time-resolved TPS calculations on the 4DCT
phases, IDDs were calculated on the average CT. Measured IDDs were compared with simulated
ones, calculating the range error for each individual spot. In total, 2025 proton spots were
individually measured and analysed. The range error of a specific spot is reported relative to its
water equivalent path length (WEPL). The mean relative range error was 1.2% (1.5 SD 2.3 %) for
the comparison with the time-resolved TPS calculations, and 1.0% (1.5 SD 2.2 %) when comparing
to TPS calculations on the average CT. The determined mean relative range errors justify the use of
3% range uncertainty for robust treatment planning in a clinical setting for thoracic indications.
1. Introduction
Proton therapy is increasingly employed for the treatment of thoracic indications, such as non-small cell lung
cancer (NSCLC) (Macdonald et al 2009). In thoracic patients, proton therapy may reduce radiation-induced
complications, such as radiation pneumonitis, which is linked to the lung dose (Palma et al 2013, Appelt et al
2014), dysphagia, which correlates with dose to the oesophagus (Belderbos et al 2005, El Naqa et al 2006, Zhu
et al 2010, Gomez et al 2012, Wijsman et al 2015) or a reduced life expectancy (two-year mortality), which is
correlated with the dose to the heart (Wang et al 2017).
© 2020 Institute of Physics and Engineering inMedicine
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The adoption of proton therapy for the treatment of thoracic tumours, especially when applied with
pencil beam scanning (PBS), has been hampered by numerous sources of uncertainty, which can potentially
have severe dose distribution degrading effects. Sources of uncertainty are linked to organ motion, interplay
effects (Bert and Rietzel 2007, Paganetti 2012) and range uncertainty, among others. Regarding the range
uncertainty, the literature suggests that uncertainty as high as 5% might be applicable for lung tissue.
In addition, it has been speculated that due to the micro-structure of the lung, which cannot be properly
detected with computed tomography (CT) scans, proton beams may be affected by an increased range
straggling effect, which would enlarge range uncertainty further (Uries et al 1986, Baumann et al 2019,
España and Paganetti 2011, Perles et al 2011, Sell et al 2012, Titt et al 2015).
Most of the recent work is based on Monte Carlo simulations, as experimental range measurements in
lung-like tissue are not straightforward to perform. Practically, it is rather challenging to maintain lung tissue
air-ventilated in ex vivo conditions. Therefore, when assessing range accuracy in lung-like tissue or
performing CT calibration for proton dose calculations, simplified tissue substitutes are often used. These
are materials similar to lung tissue in terms of physical density, however, they do not resemble the elemental
composition or structure of actual lung tissue. As a result, lung-like tissue is associated with increased range
uncertainty (Paganetti 2012). Nonetheless, artiChest (PROdesign, Heiligkreuzsteinach, Germany) (Biederer
and Heller 2003, Etzold 2020) is a phantom, which allows one to ventilate porcine lungs within a plastic shell
while mimicking the breathing motion.
Furthermore, proton radiography (PR) is a proton imaging technique introduced and investigated by
numerous groups (Parodi 2020). It relies on detecting high energy protons passing through a
sample-of-interest, positioned in the beam path. The detected signal can give insight into the water equivalent
thickness (WET) of the materials in the beam path. This can be useful, for instance, for patient positioning
or to provide an input for assessment of range uncertainty in the proton treatment planning process.
In our clinic we have adopted a PR technique (also referred to as range probing) as described by Farace
et al (2016). It relies on measuring individual integral depth-dose curves (IDDs) per shoot-through proton
pencil beams distally from the sample-of-interest, using a multi-layer ionisation chamber (MLIC). The
technique has been demonstrated to be useful for validation and optimisation of CT calibration curves by
Meijers et al (2020). In this previous study range errors were assessed in bone- and soft tissue-like phantoms.
In particular, one of the phantoms was designed as a ‘thorax’ phantom, consisting of ribs, liver, fat and
muscle attached to a low-density styrofoam block, which allowed one to assess range uncertainties in tissue
types found in the thorax, except lung tissue itself. In the previous study 1.5 SD of range errors was found to
be within the theoretical range uncertainty margin of 2.4%+ 1 mm.
The objective of this study was to experimentally assess range errors in an air-ventilated porcine lung
using PR and, in combination with the previous study, which investigated bone- and soft tissue-like
phantoms (Meijers et al 2020), to justify the choice of range uncertainty for robust thorax treatment
planning to be used in a clinical setting. In this context, range errors were determined as the discrepancy




A 4D phantom artiCHEST, which consists of two water-filled plastic shells in the shape and dimensions of a
human thorax and which can host ex vivo porcine lungs, was used (see figure 1). Ex vivo porcine lungs,
including parts of the trachea, were inspected for their intactness and were prepared for the experiment
within 24 h after extraction. The 4D phantom was configured to mimic a 4 s long breathing cycle. This was
accomplished by a two-way air pumping system. A first pump ensures vacuum in the chest cavity while the
bronchia is open to atmospheric pressure, letting the porcine lungs inflate. A second pump drives an
air-operated diaphragm, which can produce cyclical motion, following a user-defined breathing curve. A
phase-binned 4DCT scan (Somatom Definition AS, Siemens Healthineers, Erlangen, Germany) was
performed and reconstructed into scans of ten breathing phases and an average scan, all imported into TPS
(RayStation 8B, RaySearch Laboratories, Stockholm, Sweden). The breathing signal of the 4D phantom was
collected by using an ANZAI load cell (Anzai, Tokyo, Japan). The clinical CT calibration curve in the TPS
was used to correlate mass densities to the CT numbers of the 4DCT scan. The CT calibration curve was
defined following the stoichiometric method (Schneider et al 1996) with minor deviations and validation, as
described by Meijers et al (2020). Proton stopping power ratios (SPR) are calculated by the TPS based on the
provided mass density to CT number curve and internal material look-up table.
Five PR fields (i.e. frames) in the anterior-posterior (AP) direction were planned to intersect the 4D
phantom at various positions. The centres of the frames (F2–F6), as well as the setup of the 4D phantom are
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Figure 1. (A) A coronal view of the 4D phantom (average CT) showing the centres of the five proton radiography frames. (B) The
setup of the 4D phantom at the CT scanner.
Figure 2. (A) The setup of the 4D phantom and measurement equipment in the treatment room. (B) A transversal view of the 4D
phantom.
shown in figure 1. Areas, which were covered by PR frames, were subject to a motion of up to 9 mm. The
highest extent of the motion was observed in frame 2.
The AP beam direction selection was driven by two aspects: (1) currently the acquisition is technically
feasible only along the cardinal axis, and (2) the AP direction allowed one to design some of the frames (F5
and F6) in a way that only lung tissues are intersected, without soft tissue being in the beam path, this way
allowing one to focus on range errors in lung tissues.
Each PR field consisted of 81 spots separated by 5 mm and covering an area of 4× 4 cm2. All spots were
assigned an energy of 210 MeV and 1 MU/spot. On the used system the full width at half maximum
(FWHM) in air at the isocentre for spots with 210 MeV energy is 8.2 mm, according to the spot size
measurements performed during the commissioning phase.
Focusing on porcine tissue sample anatomy, proton spots in frames 5 and 6 were intersecting lung tissue
only, while frames 2, 3 and 4 were located in the mediastinum area, therefore proton spots were intersecting
soft tissue, vessels and tracheas in addition to lung tissue.
2.2. Measurements
In the proton treatment room (Proteus Plus, IBA, Louvain-la-Neuve, Belgium) the 4D phantom was
positioned on the treatment table supported by a 6D robotic positioning system and aligned to the treatment
room isocentre by using the on-board cone-beam CT (CBCT) system. The positioning accuracy of the
robotic arm is <0.5 mm, as demonstrated by recurrent quality assurance (QA) procedures.
The MLIC (Giraffe, IBA Dosimetry, Schwarzenbruck, Germany) was positioned distally from the 4D
phantom below the treatment table 63 cm from the isocentre on a slab of solid water, as shown in figure 2.
The MLIC was aligned to the isocentre along the beam axis.
Each of the five PR frames was delivered five times to ensure that various phases of the breathing cycle
were sampled by each proton spot. The delivery time of a single frame is approximately 12.5 s. The phantom
was repositioned between the frames by applying an offset with the robotic arm. The breathing signal of the
4D phantom was acquired using an ANZAI load cell during the acquisition of the PR frames. The cell was
3
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connected via an adaptor to the hose, which was operating the diaphragm. Before the experiment the ANZAI
system and proton therapy system (PTS) were synchronised to the same time server to ensure a consistent
absolute time reference for both systems. After delivery of the PR frames, treatment delivery log files of the
PTS were collected.
Since measurements were performed for fields in the AP direction, proton beams were passing through
the treatment table (Qfix Standard insert, Qfix, PA, USA). During the clinical commissioning of the patient
positioning devices the WET of the table insert was determined to be 5 mm. This value was taken into
account during data analysis, by shifting measured IDDs accordingly.
During measurements, the proton spots were passing through various materials in the 4D phantom in
the following order (see figure 2(B)): plastic shell, water, plastic shell, porcine lung, plastic shell, water and
plastic shell. The plastic shell of the 4D phantom is made of thermoplastic copolyester (physical density
according to the material data sheet is 1.27 g cm−3). The WET of the shell was experimentally verified and
agreed to the theoretical calculation within 0.5 mm, which is the uncertainty of the Giraffe-based WET
measurements (Farace et al 2016). The data set for the experimental verification consisted of PR acquisition
for frame 2 for an empty phantom (without porcine lung).
The inner surface of the plastic shell (the one in contact with lung tissue) was covered with a thin layer of
ultrasound gel, to reduce friction and avoid tearing of the lung tissue. In terms of CT numbers, the gel
corresponded to water-like material. No additional corrective actions were taken.
2.3. Analysis
PR frames were acquired during simulated breathing of the 4D phantom. A priori, it was not known which
spots would be delivered during which specific breathing phase. Therefore, treatment delivery log files
(referred to as logs) and ANZAI breathing patterns, acquired during beam delivery, were used to sort out
spots into their corresponding breathing phase. For this purpose, the method as described by Meijers et al
and in-house built scripts were used (2019). In addition to other data, logs contain information regarding
position, monitor units (MU), energy and delivery timeline for every delivered spot. From the ANZAI
breathing patterns, it is possible to determine in what phase the 4D phantom was at a specific moment in
time. By combining these two datasets, a set of ten DICOM sub-plans was created, where each sub-plan
contained only the spots corresponding to a specific breathing phase. These sub-plans per measured frame (5
frames× 5 repetitions per frame) were imported in the TPS, and each individual spot was calculated on the
corresponding phase of the 4DCT image set. The end point of a spot delivery was considered as a time stamp
for this spot. Assignment to the phase was carried out based on this time stamp. The approximate delivery
time of a spot was 5 ms. Depending on the timing, it is possible that some of the spots were partially
delivered in one phase and ended in the next one. However, this effect was considered negligible and no
additional corrective actions were taken. To simulate the MLIC, a water slab was added distally to the 4D
phantom. The TPS Monte Carlo dose calculation engine of RayStation with an accuracy of 0.5% on a dose
grid of 1 mm was used to calculate TPS-predicted IDDs. For the purpose of dose calculations, the plastic
shell of the phantom was contoured and overridden with a density of 1.27 g cm−3. TPS-calculated dose
distributions were integrated along the beam axis to create an IDD per spot.
A set of Matlab scripts based on openREGGUI open source code (Deffet et al 2017, OpenREGGUI 2020)
was used to compare measured IDDs with the simulated ones and calculate the range error for every
individual spot. The range error is obtained by the least squares method and corresponds to the optimal shift
between two IDDs. Figure 3 shows measured (MLIC) and calculated (TPS) IDDs for one of the example
spots passing through lung tissue (frame 5).
In addition to TPS calculations on the corresponding phase of the 4DCT, calculations were performed on
the average CT, since it is common practice to perform clinical treatment planning on average CTs.
3. Results
In total 2025 proton spots were individually measured and analysed. The mean water equivalent path length
(WEPL) through the 4D phantom was 143.7 mm (1 SD 32.5 mm), as determined based on MLIC
measurements. All ten phases of the 4DCT were well represented in the measurement data set. On average
203 spots (1 SD 18 spots) were associated with an individual phase. The lowest number of spots (171) was
associated with a 70% phase, and the highest number of spots (240) was associated with a 0% phase.
Although range uncertainty recipes, as suggested in the literature (Paganetti 2012), typically consist of
relative and absolute components, in practice most of the commercial TPSs allow one to specify only the
relative component for the purposes of robust optimisation or robustness evaluation. Therefore, a further on
the range error of each specific spot is evaluated relative to the WEPL of this spot through the 4D phantom,
which is determined based on MLIC measurement.
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Figure 3. Example IDDs as calculated and measured through lung tissue for one of the example spots. IDDs are shown in the
initial position prior to shift optimisation. For the shown spot a 0.7 mm shift (range error) was calculated using the least squares
method.
Figure 4. A histogram of range errors relative to the WEPL of the corresponding spot. Dose calculations in the TPS per spot are
performed on the corresponding 4DCT phase. A positive shift indicates that the measured range (MLIC) exceeds the calculated
range (TPS). The green area indicates±3% range uncertainty.
Figure 5. A histogram of range errors relative to the WEPL of the corresponding spot. Dose calculations in the TPS per spot are
performed on the average 4DCT. A positive shift indicates that the measured range (MLIC) exceeds the calculated range (TPS).
The green area indicates±3% range uncertainty.
Figure 4 shows a histogram of relative range errors for all 2025 measured spots. For this data set the TPS
dose calculation per spot was performed on the corresponding phase (0%–90%) of the 4DCT. The mean
relative range error is 1.2% (1.5 SD 2.3 %).
Figure 5 shows the histogram of relative range errors for the complete measurement data set, however, in
this case, the TPS dose calculation for all spots was performed on the average CT. The mean relative range
error here is 1.0% (1.5 SD 2.2 %).
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Figure 6. Histograms of range errors relative to the WEPL of the corresponding spot for frames 5 and 6 only. (Left) The
comparison with TPS calculated doses on corresponding 4DCT phases. (Right) The comparison with calculations performed on
the average CT. The green area indicates±3% range uncertainty.
Figure 7. (Left) A transversal view of the phantom in the area of frame 3. (Right) Overlay of the WET map of the phantom along
the proton path (coronal view PR) and relative range errors, as measured for proton spots included in frame 3. Every square
represents a proton spot. For instance, the WET gradient over the area A is 30.5 mm.
Since frames 5 and 6 were intersecting lung tissue only (see figure 1), relative range error histograms for
these frames are shown separately in figure 6.
The mean relative range error for comparison with calculations on 4DCT phases is 1.0% (1.5 SD 1.1 %),
while for comparison with calculations performed on the average CT it is 0.8% (1.5 SD 1.2 %).
4. Discussion
Comparison of the TPS-predicted and experimentally measured ranges for shoot-through proton spots
directed through a porcine lung in the 4D phantom showed good agreement, especially for spots travelling
through lung tissue only (frames 5 and 6).
The introduction of soft/lung tissue intersections in the beam path creates high WET gradients that are in
addition moving with the breathing cycles. Therefore, larger relative range errors are observed in frames
located in the mediastinum region (especially frames 3 and 4). The sensitivity of the range accuracy towards
high WET gradients in the presence of setup uncertainty is an observation that has already been reported in
the literature several times (Knopf et al 2008, Farace et al 2016, Meijers et al 2020). As an example, figure 7
shows the transversal view of the phantom in the area of frame 3. One can observe rapid changes in tissue
material in the lateral direction along the beam path of a spot (indicated by an orange line) that results in
high WET gradients. Such WET gradients are correlating with increased range errors (area A in figure 7).
The increase in range errors may be caused by local setup errors, resulting from positioning misalignments
and breathing motion. This type of error has a random component; therefore, in the case of fractionated
treatments, effects on the edges may smear out. However, further investigations should confirm this.
For technical and practical reasons, the 4D phantom was continuously kept under motion (simulating
breathing) throughout the experiment: from the assembly of the phantom, during the CT scan, until the end
of the measurement session, which is a time period of about 4–5 h. During this time, spatial configuration of
6
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Figure 8. (Left) Magnification of the phantom in a transversal view and shell contour (red), for which density override was
assigned. The DICOM image has pixel spacing of 1.07 mm. (Right) Histograms of relative range errors for frame 2 measurements,
comparing two methods for shell density correction.
the porcine tissue at some local areas may have changed, resulting in an increased setup error of some tissue
versus the proton beam. In addition, it is not possible either to guarantee or to verify that the spatial
configuration of tissue is exactly reproducible from one breathing cycle to another.
It can be observed that the evaluation performed on the average CT scan results in a slightly smaller
mean range error and SD, compared to the evaluation performed on the phases of the 4DCT scan. Although
the difference is relatively small, one possible explanation for this observation might be the more blurred
edges of individual structures in the average CT image. This might make the comparison less sensitive to
small local setup inconsistencies, which may be caused by spatial configuration variations as discussed in the
previous paragraph. However, further investigations are necessary to confirm this.
The current study is primarily focussing on range error assessment. However, the data set potentially
could be used for future investigations, in order to evaluate the effect of range mixing in more detail.
Potentially, the goodness of fit may be used as a measure for such assessments.
A small, but systematic shift of relative range errors (about 1%) was observed, meaning that the TPS
systematically overestimates the density of some materials in the beam path. This observation is potentially
caused by an ambiguity in the contour definition of the shell of the phantom. The density of the
thermoplastic shell was underestimated on the CT images (1.12 instead of 1.27 g cm−3), therefore
contouring and override of the shell was necessary. However, the shell has a curved shape, it does not have an
uniform thickness and the exact edges of the surfaces on the CT images are ambiguous, as illustrated in
figure 8. For this reason, the definition of the shell is prone to uncertainty. As mentioned before, to obtain
WET information of the shell, the PR of frame 2 was acquired for an empty phantom (without porcine
lung). This measurement was used to directly correct for the shell density discrepancy of the PR of frame 2
acquired for the assembled phantom (with porcine lung), instead of using the override structure. For this
direct correction, the mean relative range error for frame 2 (five repeated measurements) shifts towards zero
(mean relative range error 0.3% instead of 1.1%), as demonstrated in figure 8. This suggests that ambiguity
in the override approach to at least some extent may have contributed to the observed systematic shift.
The PR method used in this study is not suitable for establishing ground truth proton SPRs per tissue
type. Individual proton spots are intersecting various mixtures of materials and tissues in lateral and
longitudinal directions. Therefore, every acquired IDD is intrinsically integral by nature. To extract SPR
information per tissue/material type, acquisitions of multiple projections would be necessary (Krah et al
2015, Meyer et al 2017), which would be a step towards proton CT (Dedes et al 2018).
The main purpose of the proposed method of investigation is to assess the range calculation accuracy of
the TPS in a near-clinical setting using an end-to-end approach. In the case of major observed deviations
between TPS-calculated and measured ranges, further investigations to identify the root cause would be
necessary.
From the perspective of assessing individual tissue types corresponding to individual segments of the CT
calibration curve, it is advantageous that PR acquisitions have been performed separately for lung-like tissue
and soft/bone-like tissue (Meijers et al 2020). However, from the point of view of end-to-end testing, the
absence of bone-like tissue in the current experimental setup may be considered as a limitation. The ability to
perform PR measurements in vivo would provide additional confirmation for the made observations.
In conclusion, the range accuracy assessment in an ex vivo lung tissue using a 4D phantom showed good
agreement between calculated ranges in the TPS and the PR measurements. The mean relative range error for
a complete data set was 1.2% (1.5SD 2.3%), when TPS dose calculations were performed on the
corresponding phases of the 4DCT, and 1.0% (1.5SD 2.2%), when TPS dose calculations were performed on
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the average 4DCT. The reported results are for the evaluation, where override for the shell has been used. This
investigation, in combination with a previously conducted study (Meijers et al 2020) investigating bone- and
soft tissue-like phantoms, allowed us to confirm the use of 3% range uncertainty (1.5 SD interval) for robust
4D CT and Monte Carlo based treatment planning in a clinical setting for thoracic indications as adequate.
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